FULC Fulcrum Therapeutics, Inc.
Healthcare$6.58+0.00%OpenMarket Cap: $356.3M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$20.67
Target (Median)
$23.50
Target Range
$10.00 - $25.00
Upside from current price: 213.9%
Rating Distribution
2 Strong Buy6 Buy1 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-12-11 | Truist Securities | maintain | Buy | Buy |
| 2025-12-09 | B of A Securities | maintain | Underperform | Underperform |
| 2025-12-08 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-08 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2025-12-08 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-12-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-30 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2025-10-30 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-10-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-07-30 | RBC Capital | maintain | Sector Perform | Sector Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.32 | $361.2M | 9 |
| Sun Dec 31 | $-1.02 | $51.7M | 6 |
| Mon Dec 31 | $-0.11 | $130.7M | 4 |
| Tue Dec 31 | $0.80 | $222.7M | 2 |